乐
乐观
乐观 · 25%RFAI
$12.43
情景价格
$28.948
-0.970 (-3.35%)收盘时
Loading chart…
- 最高
- 29.950
- 开盘
- 29.950
- 成交量加权均价
- 29.28
- 成交量
- 3.17K
- 市值
- —
- 最低
- 28.948
- 成交额
- 92.88K
- 企业价值/息税折旧摊销前利润（TTM）
- 0.00
RF Acquisition Corp II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on businesses in Asia within the deep technology sector, including artificial intelligence, quantum computing, and biotechnology. The Company has neither engaged in any operations nor generated any revenues.
AI 分析 of RF Acquisition Corp II (RFAI)
卖出Given the current price of $30.00, the RSI of 42.21 indicates a lack of momentum, and the forward P/E ratio is not applicable, suggesting uncertainty in future earnings. The stock has dropped 16.27% over the last five days, indicating a bearish trend. The main risk is the significant decline in net income, which fell to $93,702 in Q1 2026, down from over $1 million in Q4 2024, highlighting potential operational challenges.
估值指标
RF Acquisition Corp II（RFAI）当前预期市盈率为 0.00，5 年平均预期市盈率为 0.00。
Alphio AI 对 RFAI 的价格情景
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重（25 / 50 / 25），不构成保证。
持有 RFAI 的大户
事件时间线
资讯
9.508-24PRnewswireThe9 Reports Strong Q2 2026 Financial Results with AI Expansion
8.508-21NASDAQ.COMRF Acquisition Corp II Shares Surge 230% Following Merger Announcement
8.510-02SeekingAlphaNanyang Biologics, supported by The9, to become publicly traded through $1.5B SPAC merger; stock prices rise
- 8.510-02PRnewswire
The9's Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II
RFAI 常见问题 —— 由 Alphio AI 解答
RF Acquisition Corp II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on businesses in Asia within the deep technology sector, including artificial intelligence, quantum computing, and biotechnology. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.
Given the current price of $30.00, the RSI of 42.21 indicates a lack of momentum, and the forward P/E ratio is not applicable, suggesting uncertainty in future earnings. The stock has dropped 16.27% over the last five days, indicating a bearish trend. The main risk is the significant decline in net income, which fell to $93,702 in Q1 2026, down from over $1 million in Q4 2024, highlighting potential operational challenges.
社区
更多 ↗暂无帖子
注册或登录后参与讨论相关文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。